SCHEMBL1356205

SCHEMBL1356205

CC(C)(SC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CES1 P23141 5/20 0.41
CES2 O00748 4/20 0.41
DAO P14920 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
SLC22A12 Q96S37 2/20 0.40
KMT2A Q03164 2/20 0.39
ELANE P08246 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.38
POLB P06746 2/20 0.38
CYP3A4 P08684 1/20 0.38
PARP1 P09874 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2774081 0.83 NPC1 (0.44) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL822806 0.80 EPHX1 (0.42) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL2773946 0.78 CA12 (0.41) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL4298143 0.77 POLB (0.51) TSHRALDH1A1TDP1KMT2ANPC1
SCHEMBL10633427 0.76 TRPA1 (0.39) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL27780014 0.74 CES1 (0.52) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL27892938 0.72 CES1 (0.42) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL1271166 0.71 CES1 (0.50) TSHRALDH1A1HSD17B10TDP1CES1
SCHEMBL9434643 0.71 PAM (0.50) TSHRALDH1A1TDP1CES1CES2
SCHEMBL13377791 0.71 EPHX1 (0.41) TSHRALDH1A1HSD17B10TDP1CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166048-B Method for preparing S- (-) -benzoyl mercapto-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2024-01-05 CN claimed
CN-113166048-B Method for preparing S- (-) -benzoyl mercapto-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2024-01-05 CN disclosed
CN-113166048-B Method for preparing S- (-) -benzoyl mercapto-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2024-01-05 CN disclosed
CN-113166048-B Method for preparing S- (-) -benzoyl mercapto-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2024-01-05 CN disclosed
EP-3912970-A4 METHOD FOR PREPARING S-(-)-BENZOYLMERCAPTO-2-METHYLPROPANOIC ACID COMPOUND Zhejiang Huahai Pharmaceutical Co., Ltd. (CN) 2022-03-09 EP disclosed
CN-113166048-A Method for preparing S- (-) -benzoyl sulfydryl-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2021-07-23 CN disclosed
CN-113166048-A Method for preparing S- (-) -benzoyl sulfydryl-2-methylpropanoic acid compound 浙江华海药业股份有限公司 2021-07-23 CN disclosed
EP-3277736-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2018-02-07 EP disclosed
WO-2016156473-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2016-10-06 WO disclosed
EP-2389360-A2 A PROCESS FOR THE PREPARATION OF ZOFENOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF Glenmark Generics Limited (IN) 2011-11-30 EP disclosed
US-20110281928-A1 Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof GLENMARK GENERICS LTD (IN) 2011-11-17 US disclosed
US-20110253651-A1 Drying rack with wrap-around cover BEHJAT MOHAMMAD KAZEM 2011-10-20 US disclosed
WO-2010084515-A2 A PROCESS FOR THE PREPARATION OF ZOFENOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF GLENMARK GENERICS LIMITED (IN) 2010-07-29 WO disclosed
EP-0903346-A1 SYDNONE IMINE DERIVATIVES Chugai Seiyaku Kabushiki Kaisha (JP) 1999-03-24 EP disclosed
US-4559178-A Resolution of 3-benzoylthio-2-methyl-propanoic acid with (+)-dehydroabietylamine AMERICAN HOME PRODUCTS CORPORATION (US) 1985-12-17 US disclosed
EP-0008831-B1 PROCESS FOR THE PREPARATION OF 1-(3-MERCAPTO-2-D-METHYL-PROPIONYL)-L-PROLINE AND DERIVATIVES THEREOF Océ-Andeno B.V. (NL) 1982-03-17 EP disclosed
EP-0008833-A1 Optically active derivatives of mercaptoisobutyric acid and a process for preparing them Océ-Andeno B.V. (NL) 1980-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281928-A1 Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof ACE, REN, PEPD TSHR 4797/4885ALDH1A1 963/4885HSD17B10 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.